Meningeal Carcinomatosis — Trials

Meningeal Carcinomatosis — Trials · CancerIndex

Clinical trials

Registered studies

59 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 28
Recruiting: 12
Ph III recruiting: 0
Growth YoY: —
Industry share: 7%
Top sponsor: Guangzhou Medical University
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (5)

clinicaltrialsPublishedShowing 1–7 of 7 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06812871	High-dose Furmonertinib Combined With Bevacizumab and Intrathecal Pemetrexed Chemotherapy in Patients With EGFR-mutated Non-small Cell Lung Cancer and Meningeal Metastasis	completed	Phase 2	46	Sun Yat-sen UniversityOTHER	1	Aug 14, 2026	clinicaltrials
NCT04343573	Proton Craniospinal Radiation Therapy vs. Partial Photon Radiation Therapy for Leptomeningeal Metastasis From Solid Tumors	completed	Phase 2	102	Memorial Sloan Kettering Cancer CenterOTHER	1	Feb 27, 2026